Cite

HARVARD Citation

    Blanchet, B. et al. (2018). A PK/PD study of Delta-4 abiraterone metabolite in metastatic castration-resistant prostate cancer patients. Pharmacological research. pp. 56-61. [Online]. 
  
Back to record